Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Blood (2024) 144 (8): 873–887.

https://doi.org/10.1182/blood.2024024499

Published: 2024

Includes: Supplemental data

Journal Articles

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Blood (2016) 128 (24): 2819–2823.

https://doi.org/10.1182/blood-2016-05-713099

Published: 2016

Includes: Supplemental data

Journal Articles

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Blood (2016) 128 (2): 297–312.

https://doi.org/10.1182/blood-2016-03-706317

Published: 2016

Includes: Supplemental data

Journal Articles

The CXCR4/STAT3/IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia (CLL) and Can be Modulated By Lenalidomide

Blood (2015) 126 (23): 1709.

https://doi.org/10.1182/blood.V126.23.1709.1709

Published: 2015

Journal Articles

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

Blood (2014) 124 (13): 2034–2045.

https://doi.org/10.1182/blood-2014-04-571125

Published: 2014

Includes: Supplemental data

Journal Articles

CD161 Expression Identifies a Distinct Subset Of Drug-Effluxing Viral-Specific Memory CD4+ T Cells That Preferentially Survive Cytotoxic Chemotherapy

MD Muharrem Muftuoglu, Abdullah Alsuliman, PhD, Ahmad Khoder, MD, Yong-Oon Ahn, PhD, Enli Liu, MD, MS, Claude Chew, Amir Hamdi, MD, Takuya Sekine, Anushruti Sarvaria, Nichola Cooper, MD, Hugues de Lavallade, MD, David Marin, MD, Kate Stringaris, MD, MRCP, FRCPath, Michael R. Verneris, MD, Elizabeth J Shpall, MD, Katayoun Rezvani, MD, PhD

Blood (2013) 122 (21): 2024.

https://doi.org/10.1182/blood.V122.21.2024.2024

Published: 2013

Journal Articles

B Cell With Regulatory Function Are Enriched Within Transitional and IgM Memory B Cell Subsets In Healthy Donors But Are Reduced and Functionally Impaired In Patients With Chronic Graft-Versus-Host Disease

Blood (2013) 122 (21): 4478.

https://doi.org/10.1182/blood.V122.21.4478.4478

Published: 2013

Journal Articles

Natural Killer Cells In Pediatric Acute Lymphoblastic Leukemia Patients At Diagnosis Demonstrate An Inhibitory Phenotype and Reduced Cytolytic Capacity

Rayne H. Rouce, MD, Takuya Sekine, Gerrit Weber, MD, Claude Chew, Katayoun Rezvani, M.D., PhD, Catherine M. Bollard, MD, FRACP, FRCPA, Karen R Rabin, MD, PhD

Blood (2013) 122 (21): 1397.

https://doi.org/10.1182/blood.V122.21.1397.1397

Published: 2013

Journal Articles

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling

Blood (2013) 122 (2): 227–238.

https://doi.org/10.1182/blood-2012-11-465039

Published: 2013

Includes: Supplemental data

Journal Articles

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Blood (2011) 118 (21): 3753.

https://doi.org/10.1182/blood.V118.21.3753.3753

Published: 2011

Journal Articles

2009 Pandemic Influenza A H1N1 Vaccination In the Patients with Hematologic Malignancies: Requirement for Repeated Dosing to Optimize Seroprotection

Blood (2010) 116 (21): 677.

https://doi.org/10.1182/blood.V116.21.677.677

Published: 2010

Journal Articles

A Distinct Signature of Natural Killer Cell KIR Gene Frequencies In Secondary AML Compared with De Novo AML and Normal Controls

Kate Stringaris, MD, MRCP, FRCPath, A. John Barrett, MD, Robert Hills, MA, MSc, DPhil, David C Linch, MD, FMedSci, Rosemary Gale, PhD, Christopher Allen, Paula Garland, MBBS, MRCP, Ruhena Sargent, Hugues de Lavallade, Abdullah Alsuliman, Ahmad Khoder, Dr, Ian H Gabriel, Dr, Takuya Sekine, Alan Burnett, Katayoun Rezvani, Jane F. Apperley

Blood (2010) 116 (21): 1697.

https://doi.org/10.1182/blood.V116.21.1697.1697

Published: 2010

NARROW

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

The CXCR4/STAT3/IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia (CLL) and Can be Modulated By Lenalidomide

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

CD161 Expression Identifies a Distinct Subset Of Drug-Effluxing Viral-Specific Memory CD4+ T Cells That Preferentially Survive Cytotoxic Chemotherapy

B Cell With Regulatory Function Are Enriched Within Transitional and IgM Memory B Cell Subsets In Healthy Donors But Are Reduced and Functionally Impaired In Patients With Chronic Graft-Versus-Host Disease

Natural Killer Cells In Pediatric Acute Lymphoblastic Leukemia Patients At Diagnosis Demonstrate An Inhibitory Phenotype and Reduced Cytolytic Capacity

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

2009 Pandemic Influenza A H1N1 Vaccination In the Patients with Hematologic Malignancies: Requirement for Repeated Dosing to Optimize Seroprotection

A Distinct Signature of Natural Killer Cell KIR Gene Frequencies In Secondary AML Compared with De Novo AML and Normal Controls

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only